Abstract
Difficulties in the proper use of the gelatin-viscosity test for assay of proteolytic activity have been discussed. It is the author's opinion that for routine clinical diagnostic studies the Andersen-Early test is sufficiently accurate and much simpler. The considerations presented regarding measurement of pancreatic function and interpretation of data justify a critical attitude toward accepting some of the published data regarding normal and partial or progressive loss of pancreatic function. That such possibilities may exist is not denied, but the actual incidence must be determined by proper application and interpretation of results from sound methods for assay of pancreatic enzymes in duodenal fluid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
